What are the treatment options for muscle pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Muscle Pain

For acute non-low back musculoskeletal pain, start with topical NSAIDs with or without menthol gel as first-line therapy, followed by oral NSAIDs or acetaminophen if needed, while avoiding opioids and using muscle relaxants only when necessary with preference for tizanidine over other agents. 1

First-Line Treatment: Topical NSAIDs

  • Topical NSAIDs with or without menthol gel should be the initial treatment to reduce pain, improve physical function, and enhance treatment satisfaction 1
  • This represents a strong recommendation based on moderate-certainty evidence from the American College of Physicians and American Academy of Family Physicians 1
  • Topical formulations minimize systemic absorption and associated cardiovascular risks compared to oral NSAIDs 1

Second-Line Treatment: Oral Analgesics

Oral NSAIDs and Acetaminophen

  • Oral NSAIDs are recommended to reduce pain and improve physical function when topical therapy is insufficient 1
  • Acetaminophen is an appropriate alternative specifically for pain reduction 1, 2
  • Acetaminophen temporarily relieves minor aches and pains due to muscular aches, with dosing of 2 caplets every 8 hours (maximum 6 caplets in 24 hours, not exceeding 10 days without physician direction) 2
  • In emergency department studies of acute musculoskeletal injuries, ibuprofen 800 mg and acetaminophen 1 g showed similar pain reduction (approximately 20 mm on visual analog scale), with no additional benefit from combining them 3

Stepped-Care Approach for Patients with Cardiovascular Disease

For patients with known cardiovascular disease or risk factors, follow this hierarchy 1:

  1. Start with acetaminophen, aspirin, tramadol, or short-term narcotic analgesics 1
  2. Progress to nonacetylated salicylates if needed 1
  3. Consider non-COX-2 selective NSAIDs (such as naproxen) if initial therapy is insufficient 1
  4. NSAIDs with COX-2 selectivity should only be used when intolerable discomfort persists despite stepped-care attempts, using the lowest effective dose for the shortest time 1
  5. Ibuprofen should not be used because it blocks the antiplatelet effects of aspirin 1

Critical Cardiovascular Warnings for NSAIDs

  • NSAIDs increase risk of heart attack, stroke, and death, particularly in patients with established cardiovascular disease 1, 4
  • Do not use NSAIDs right before or after coronary artery bypass graft surgery 4
  • NSAIDs increase risk of bleeding, ulcers, and gastrointestinal perforation, especially with longer use, higher doses, advanced age, alcohol use, smoking, or concurrent use of corticosteroids, anticoagulants, SSRIs, or SNRIs 4
  • Avoid NSAIDs after 30 weeks of pregnancy due to potential harm to the unborn baby 4

Muscle Relaxants: Use Sparingly and Selectively

When to Consider Muscle Relaxants

  • Muscle relaxants should be reserved for situations where analgesics alone are insufficient 5, 6
  • Adding a muscle relaxant to an NSAID or acetaminophen provides greater short-term pain relief than analgesic monotherapy, though this increases CNS adverse events 5
  • The term "muscle relaxant" is misleading—these drugs do not relieve muscle spasm through direct muscle relaxation; their effects are nonspecific 5

Preferred Agent: Tizanidine

  • Tizanidine is recommended as the safest muscle relaxant alternative due to its favorable efficacy and safety profile 5
  • Start at 2-4 mg with upward titration as needed 5
  • Monitor for hepatotoxicity, which is generally reversible 5

Agents to Avoid

  • Avoid benzodiazepines (diazepam, lorazepam) due to abuse potential, high fall risk in older adults, and lack of proven benefit 5, 7
  • In rheumatoid arthritis patients, benzodiazepines (diazepam, triazolam) showed no pain improvement over 24 hours to one week, but caused significant drowsiness and dizziness (number needed to harm = 3) 7
  • Carisoprodol is a controlled substance with substantial abuse potential, barbiturate-like action, and severe withdrawal symptoms (insomnia, vomiting, tremors, anxiety, hallucinations) 6
  • Carisoprodol should be avoided despite showing superiority over diazepam in some trials, as non-benzodiazepine alternatives (cyclobenzaprine, methocarbamol, metaxalone) have similar efficacy without controlled substance classification 6

Alternative Muscle Relaxant Options

  • Cyclobenzaprine is structurally similar to tricyclic antidepressants with expected anticholinergic effects 5
  • For elderly patients requiring muscle relaxant therapy, baclofen is preferred, starting at 5 mg three times daily with gradual titration 6
  • Muscle relaxants are effective for short-term (2-3 weeks maximum) symptomatic relief in acute musculoskeletal conditions 6

Adjuvant Therapies

Non-Pharmacological Interventions

  • Acupuncture is recommended to reduce pain and improve physical function in acute musculoskeletal injuries 1
  • Transcutaneous electrical nerve stimulation (TENS) can reduce pain 1
  • Physical activity, physical therapy, and rehabilitation should be offered based on clinical indication 1

Adjuvant Analgesics for Specific Pain Types

For neuropathic or chronic widespread muscle pain (such as fibromyalgia):

  • Duloxetine (SNRI) and tricyclic antidepressants are effective for neuropathic pain and fibromyalgia 1
  • Gabapentin and pregabalin (gabapentinoids) are recommended for neuropathic pain and fibromyalgia 1
  • These adjuvant analgesics can be used alone or coadministered with opioids to enhance analgesia 1

For aromatase inhibitor-associated muscle pain in breast cancer survivors:

  • Acupuncture and intensive exercise regimens have demonstrated statistically significant improvement 1
  • NSAIDs and acetaminophen are often not responsive for this specific pain type 1

What NOT to Do

Avoid Opioids

  • The American College of Physicians and American Academy of Family Physicians recommend against treating acute musculoskeletal pain with opioids, including tramadol 1
  • This is a conditional recommendation based on low-certainty evidence, but reflects the significant risks of opioid use disorder and adverse events 1
  • If opioids are deemed necessary, use the lowest dose possible, reevaluate regularly, and consider pain treatment agreements 1

Duration Limits

  • Do not use acetaminophen for more than 10 days without physician direction 2
  • Do not use over-the-counter NSAIDs for more than 10 days without consulting a healthcare provider 4
  • Muscle relaxants should be limited to short-term use (2-3 weeks maximum) 6

Special Populations

Older Adults

  • Muscle relaxants carry increased fall risk, particularly in older persons 5
  • Benzodiazepines have a high risk profile in older adults that usually obviates any potential benefit 5
  • If muscle relaxant therapy is required in elderly patients, baclofen is preferred 6

Patients with Cardiovascular Disease

  • Follow the stepped-care approach outlined above, starting with acetaminophen or non-acetylated salicylates 1
  • Prescribe the lowest dose required to control symptoms 1
  • Consider adding aspirin 81 mg and a proton-pump inhibitor for patients at increased risk of thrombotic events, though this may not provide sufficient protection 1

Cancer Survivors

  • Assess musculoskeletal symptoms at each clinical encounter 1
  • Offer acetaminophen, NSAIDs, physical activity, and/or acupuncture for pain 1
  • For bone pain, consider osteoclast inhibitors (bisphosphonates or denosumab) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Safest Muscle Relaxant for Muscle Sprain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Carisoprodol Efficacy and Safety Compared to Other Muscle Relaxants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Muscle relaxants for pain management in rheumatoid arthritis.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.